Effect of hypertonic vs isotonic saline solution on responses to sublethal Escherichia coli endotoxemia in horses.
Cardiovascular responses to sublethal endotoxin infusion (Escherichia coli, 50 micrograms/ml in lactated Ringer solution at 100 ml/h until pulmonary arterial pressure increased by 10 mm of Hg) were measured 2 times in 5 standing horses. In a 2-period crossover experimental design, horses were either administered hypertonic (2,400 mosm/kg of body weight, IV) or isotonic (300 mosm/kg, IV) NaCl solution after endotoxin challenges. Each solution was administered at a dose of 5 ml/kg (infusion rate, 80 ml/min). Complete data sets (mean arterial, central venous, and pulmonary arterial pressures, pulmonary arterial blood temperature, cardiac output, total peripheral vascular resistance, heart rate, plasma osmolality, plasma concentration of Na, K, Cl, and total protein, blood lactate concentration, and PCV) were collected at 0 (baseline, before endotoxin infusion), 0.25, 1, 1.5, 2, 2.5, 3, 3.5, 4, and 4.5 hours after initiation of the endotoxin infusion. Blood constituents alone were measured at 0.5 hour and cardiovascular variables alone were evaluated at 0.75 hour. By 0.25 hour, endotoxin infusion was completed, a data set was collected, and saline infusion was initiated. By 0.75 hour, saline solutions had been completely administered. Mean (+/- SEM) cardiac output decreased (99.76 +/- 3.66 to 72.7 +/- 2.35 ml/min/kg) and total peripheral resistance (1.0 +/- 0.047 to 1.37 +/- 0.049 mm of Hg/ml/min/kg) and pulmonary arterial pressure (33.4 +/- 0.86 to 58.3 +/- 1.18 mm of Hg) increased for both trials by 0.25 hour after initiation of the endotoxin infusion and prior to fluid administration. For the remainder of the protocol, cardiac output was increased and total peripheral resistance was decreased during the hypertonic, compared with the isotonic, saline trial.(ABSTRACT TRUNCATED AT 250 WORDS)
Department of Veterinary Clinical Sciences, Louisiana State University School of Veterinary Medicine, Baton Rouge 70803.
J J
JJ
Bertone
K A
KA
Gossett
K E
KE
Shoemaker
A L
AL
Bertone
H L
HL
Schneiter
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D002200:Capillary Resistance / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004927:Escherichia coli Infections / Q000097:blood / Q000662:veterinary*; D006339:Heart Rate / Q000187:drug effects; D006734:Horse Diseases / Q000097:blood / Q000628:therapy*; D006736:Horses; D007262:Infusions, Intravenous / Q000662:veterinary; D007552:Isotonic Solutions; D008297:Male; D011651:Pulmonary Artery / Q000502:physiology*; D012462:Saline Solution, Hypertonic / Q000627:therapeutic use*; D012772:Shock, Septic / Q000097:blood / Q000628:therapy / Q000662:veterinary*; D012965:Sodium Chloride / Q000627:therapeutic use*; D013997:Time Factors
D007552:Isotonic Solutions; D012462:Saline Solution, Hypertonic; D012965:Sodium Chloride